JFL Life Sciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	744.78	820.42	465.48	428.3	335.9	327.7
Other Revenue	-	-	4.72	13.8	7.2	-
Revenue	744.78	820.42	470.19	442.1	343.1	327.7
Revenue Growth (YoY)	-1.19%	74.49%	6.35%	28.85%	4.70%	8.61%
Cost of Revenue	583.82	663.35	401.03	349.4	258.8	288.9
Gross Profit	160.97	157.07	69.17	92.7	84.3	38.8
Selling, General & Admin	7.96	12.62	9.16	18.6	15.6	9.6
Other Operating Expenses	77.16	62.46	9.48	21.4	9.3	7.4
Operating Expenses	95.59	85.01	23.06	44	27.3	19.6
Operating Income	65.38	72.07	46.11	48.7	57	19.2
Interest Expense	-11.45	-9.93	-7.43	-13.2	-20.5	-12.3
Interest & Investment Income	0.08	0.08	0.26	-	1	0.8
Currency Exchange Gain (Loss)	-	-	-	-	0.4	0.1
Other Non Operating Income (Expenses)	-1.05	-0.86	-1.01	1.7	-	-
Pretax Income	52.95	61.35	37.93	37.2	37.9	7.8
Income Tax Expense	17.79	19.77	4.92	9.1	9.9	2.2
Net Income	35.17	41.59	33	28.1	28	5.6
Net Income to Common	35.17	41.59	33	28.1	28	5.6
Net Income Growth	-34.40%	26.00%	17.45%	0.36%	400.00%	55.38%
Shares Outstanding (Basic)	44	33	33	29	20	18
Shares Outstanding (Diluted)	44	33	33	29	20	18
Shares Change (YoY)	33.13%	-	13.37%	42.40%	11.93%	10.70%
EPS (Basic)	0.80	1.26	1.00	0.97	1.37	0.31
EPS (Diluted)	0.80	1.26	1.00	0.97	1.37	0.31
EPS Growth	-50.74%	26.00%	3.57%	-29.52%	346.69%	40.37%
Free Cash Flow	26.81	-39.27	22.95	-90.5	6.3	-63.3
Free Cash Flow Per Share	0.61	-1.19	0.70	-3.11	0.31	-3.47
Dividend Per Share	-	-	0.083	-	-	-
Gross Margin	21.61%	19.14%	14.71%	20.97%	24.57%	11.84%
Operating Margin	8.78%	8.78%	9.81%	11.02%	16.61%	5.86%
Profit Margin	4.72%	5.07%	7.02%	6.36%	8.16%	1.71%
Free Cash Flow Margin	3.60%	-4.79%	4.88%	-20.47%	1.84%	-19.32%
EBITDA	75.5	81.65	50.19	53	60.7	21.8
EBITDA Margin	10.14%	9.95%	10.67%	11.99%	17.69%	6.65%
D&A For EBITDA	10.12	9.58	4.08	4.3	3.7	2.6
EBIT	65.38	72.07	46.11	48.7	57	19.2
EBIT Margin	8.78%	8.78%	9.81%	11.02%	16.61%	5.86%
Effective Tax Rate	33.59%	32.22%	12.98%	24.46%	26.12%	28.21%
Revenue as Reported	744.99	820.52	470.61	444.7	344.8	328.6
Advertising Expenses	-	2.51	0.01	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.